IBDEI148 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19911,0)
 ;;=600.11^^112^1196^21
 ;;^UTILITY(U,$J,358.3,19911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19911,1,3,0)
 ;;=3^600.11
 ;;^UTILITY(U,$J,358.3,19911,1,4,0)
 ;;=4^NOD PROSTATE W UR OBST
 ;;^UTILITY(U,$J,358.3,19911,2)
 ;;=^329935
 ;;^UTILITY(U,$J,358.3,19912,0)
 ;;=600.20^^112^1196^5
 ;;^UTILITY(U,$J,358.3,19912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19912,1,3,0)
 ;;=3^600.20
 ;;^UTILITY(U,$J,358.3,19912,1,4,0)
 ;;=4^BPH-LOCALZED W/O UR OBST
 ;;^UTILITY(U,$J,358.3,19912,2)
 ;;=^329936
 ;;^UTILITY(U,$J,358.3,19913,0)
 ;;=600.21^^112^1196^4
 ;;^UTILITY(U,$J,358.3,19913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19913,1,3,0)
 ;;=3^600.21
 ;;^UTILITY(U,$J,358.3,19913,1,4,0)
 ;;=4^BPH-LOCALIZED W UR OBST
 ;;^UTILITY(U,$J,358.3,19913,2)
 ;;=^329937
 ;;^UTILITY(U,$J,358.3,19914,0)
 ;;=788.99^^112^1196^28
 ;;^UTILITY(U,$J,358.3,19914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19914,1,3,0)
 ;;=3^788.99
 ;;^UTILITY(U,$J,358.3,19914,1,4,0)
 ;;=4^URINARY TRACT SYMPTOMS
 ;;^UTILITY(U,$J,358.3,19914,2)
 ;;=^273391
 ;;^UTILITY(U,$J,358.3,19915,0)
 ;;=585.1^^112^1196^8
 ;;^UTILITY(U,$J,358.3,19915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19915,1,3,0)
 ;;=3^585.1
 ;;^UTILITY(U,$J,358.3,19915,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE 1
 ;;^UTILITY(U,$J,358.3,19915,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,19916,0)
 ;;=585.2^^112^1196^9
 ;;^UTILITY(U,$J,358.3,19916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19916,1,3,0)
 ;;=3^585.2
 ;;^UTILITY(U,$J,358.3,19916,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE II
 ;;^UTILITY(U,$J,358.3,19916,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,19917,0)
 ;;=585.3^^112^1196^10
 ;;^UTILITY(U,$J,358.3,19917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19917,1,3,0)
 ;;=3^585.3
 ;;^UTILITY(U,$J,358.3,19917,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE III
 ;;^UTILITY(U,$J,358.3,19917,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,19918,0)
 ;;=585.4^^112^1196^11
 ;;^UTILITY(U,$J,358.3,19918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19918,1,3,0)
 ;;=3^585.4
 ;;^UTILITY(U,$J,358.3,19918,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE IV
 ;;^UTILITY(U,$J,358.3,19918,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,19919,0)
 ;;=585.5^^112^1196^12
 ;;^UTILITY(U,$J,358.3,19919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19919,1,3,0)
 ;;=3^585.5
 ;;^UTILITY(U,$J,358.3,19919,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE V
 ;;^UTILITY(U,$J,358.3,19919,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,19920,0)
 ;;=585.9^^112^1196^7
 ;;^UTILITY(U,$J,358.3,19920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19920,1,3,0)
 ;;=3^585.9
 ;;^UTILITY(U,$J,358.3,19920,1,4,0)
 ;;=4^CHR KIDNEY DISEASE NOS
 ;;^UTILITY(U,$J,358.3,19920,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,19921,0)
 ;;=584.8^^112^1196^1
 ;;^UTILITY(U,$J,358.3,19921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19921,1,3,0)
 ;;=3^584.8
 ;;^UTILITY(U,$J,358.3,19921,1,4,0)
 ;;=4^ACUTE KIDNEY FAILURE NEC
 ;;^UTILITY(U,$J,358.3,19921,2)
 ;;=^338531
 ;;^UTILITY(U,$J,358.3,19922,0)
 ;;=585.6^^112^1196^14
 ;;^UTILITY(U,$J,358.3,19922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19922,1,3,0)
 ;;=3^585.6
 ;;^UTILITY(U,$J,358.3,19922,1,4,0)
 ;;=4^END STAGE RENAL DISEASE
 ;;^UTILITY(U,$J,358.3,19922,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,19923,0)
 ;;=588.89^^112^1196^16
 ;;^UTILITY(U,$J,358.3,19923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19923,1,3,0)
 ;;=3^588.89
 ;;^UTILITY(U,$J,358.3,19923,1,4,0)
 ;;=4^IMPAIR REN FUNCT DIS NEC
 ;;^UTILITY(U,$J,358.3,19923,2)
 ;;=^88036
 ;;^UTILITY(U,$J,358.3,19924,0)
 ;;=589.1^^112^1196^26
 ;;^UTILITY(U,$J,358.3,19924,1,0)
 ;;=^358.31IA^4^2
